CMS Drug Price Negotiation Guidance Updates with Rachel Sachs
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
CMS Drug Price Negotiation Guidance Updates with Rachel Sachs
-
Narrated by:
-
By:
About this listen
Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back to the pod to discuss CMS' final guidance for the latest round of the Medicare drug price negotiation program.
Related Articles:
- Administration Releases Medicare Drug Price Negotiation Program Final Guidance For 2028 (Health Affairs Forefront)
- The Role of Combination Drugs in the Medicare Drug Price Negotiation Program (JAMA)
- Articulating policy options regarding implementation of the Medicare drug price negotiation program’s renegotiation provision (Brookings Institution)
- Eye on The IRA (Health Affairs)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.